Exozymes (EXOZ) Total Liabilities (2023 - 2024)
Exozymes (EXOZ) has disclosed Total Liabilities for 2 consecutive years, with $7.2 million as the latest value for Q3 2024.
- Quarterly Total Liabilities rose 1279.57% to $7.2 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $7.2 million through Sep 2024, up 1279.57% year-over-year, with the annual reading at $3.9 million for FY2023, N/A changed from the prior year.
- Total Liabilities for Q3 2024 was $7.2 million at Exozymes, up from $2.3 million in the prior quarter.
- The five-year high for Total Liabilities was $7.2 million in Q3 2024, with the low at -$607141.0 in Q3 2023.